FULGENT GENETICS, INC. Increase (Decrease) in Other Current Assets
FULGENT GENETICS, INC. (FLGT) reported Increase (Decrease) in Other Current Assets of -$91.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2019-03-22
- FULGENT GENETICS, INC. increase (decrease) in other current assets for the quarter ending 2018-12-31 was $124.00K.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for the quarter ending 2018-09-30 was -$193.00K, a 126.77% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for the quarter ending 2018-06-30 was -$147.00K, a 130.50% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for the quarter ending 2018-03-31 was $125.00K, a 63.56% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for fiscal 2018 was -$91.00K, a 105.92% decline from fiscal 2017.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for fiscal 2017 was $1.54M, a 303.41% increase from fiscal 2016.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for fiscal 2016 was $381.00K, a 133.74% increase from fiscal 2015.
- FULGENT GENETICS, INC. increase (decrease) in other current assets for fiscal 2015 was $163.00K, a 18.12% increase from fiscal 2014.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$69.00K derived: sum of 2 quarters · filed 2019-03-22 | -$216.00K derived: sum of 3 quarters · filed 2019-03-22 | -$91.00K 10-K · filed 2019-03-22 |
| 2018-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$340.00K derived: sum of 2 quarters · filed 2018-11-09 | -$215.00K 10-Q · filed 2018-11-09 | -$224.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2018-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$22.00K 10-Q · filed 2018-08-13 | -$31.00K derived: sum of 3 quarters · filed 2019-03-22 | $690.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2018-03-31 | $125.00K 10-Q · filed 2018-05-14 | $116.00K derived: sum of 2 quarters · filed 2019-03-22 | $837.00K derived: sum of 3 quarters · filed 2019-03-22 | $1.32M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $712.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.19M derived: sum of 3 quarters · filed 2019-03-22 | $1.54M 10-K · filed 2019-03-22 |
| 2017-09-30 | $721.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.20M derived: sum of 2 quarters · filed 2018-11-09 | $1.55M 10-Q · filed 2018-11-09 | $1.53M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $825.00K 10-Q · filed 2018-08-13 | $806.00K derived: sum of 3 quarters · filed 2018-08-13 | $1.00M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $343.00K 10-Q · filed 2018-05-14 | $324.00K derived: sum of 2 quarters · filed 2018-05-14 | $522.00K derived: sum of 3 quarters · filed 2018-05-14 | $643.00K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $179.00K derived: sum of 2 quarters · filed 2018-03-20 | $300.00K derived: sum of 3 quarters · filed 2018-03-20 | $381.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $319.00K derived: sum of 2 quarters · filed 2017-11-13 | $400.00K 10-Q · filed 2017-11-13 | $374.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $202.00K 10-Q · filed 2017-08-14 | $176.00K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | $81.00K 10-Q · filed 2017-05-09 | $55.00K derived: sum of 2 quarters · filed 2017-05-09 | ||
| 2015-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $163.00K 10-K · filed 2017-03-17 | ||
| 2015-09-30 | $189.00K 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | $138.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |